Difference in the early clinical course between children with type 1 diabetes having a single antibody and those having multiple antibodies against pancreatic β-cells-Reference-Cited by-同舟云学术

Difference in the early clinical course between children with type 1 diabetes having a single antibody and those having multiple antibodies against pancreatic β-cells

Published:2023 Issue:4 Volume:70 Page:385-391
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Terada Hiroki¹,Urakami Tatsuhiko¹,Nagano Nobuhiko¹,Mine Yusuke¹,Kuwabara Remi¹,Aoki Masako¹,Suzuki Junichi¹,Morioka Ichiro¹

Affiliation:

1. Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo 173-8610, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/70/4/70_EJ22-0432/_pdf

Reference35 articles.

1. 1 Cooper JJ, Haller MJ, Greenbaum CJ, Ziegler AG, Wherrett DK, et al. (2018) ISPAD Clinical Practice Consensus Guidelines 2018: stages of type 1 diabetes in children and adolescents. Pediatr Diabetes 19 Suppl 27: 20–27.

2. 2 Mayer-Davis EJ, Kahkoska AR, Jefferies C, Dabelea D, Balde N, et al. (2018) ISPAD Clinical Practice Consensus Guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 19 Suppl 27: 7–19.

3. 3 Regnell SE, Lernmark A (2017) Early prediction of autoimmune (type 1) diabetes. Diabetologia 60: 1370–1381.

4. 4 Vehik K, Bonifacio E, Lernmark A, Yu L, Williams A, et al. (2020) Hierarchical order of distinct autoantibody spreading and progression type 1 diabetes in the TEDDY study. Diabetes Care 43: 2066–2073.

5. 5 Ziegler AG, Rewers M, Simell O, Simell T, Lempainen J, et al. (2013) Seroconversion to multiple islet autoantibodies and risk of progression to disease in children. JAMA 309: 2473–2479.